Research Article

Attenuation of Liver Injury via Bicyclol–Bovine Serum Albumin Nanopreparation using a Green Synthetic Approach

Figure 6

Pharmacokinetic behavior and therapeutics of BIC-NPs: (a) plasma concentration–time profiles of BIC in rats after oral administration of BIC suspended in 0.5% CMC or injection of BIC-NPs (dose, 5 mg/kg). Data are expressed as mean ± SD (n = 5); (b) representative H&E staining of liver from liver injury rats (for methotrexate) treated with BIC and BIC-NPs; (c and d) ALT and AST levels of liver injury rats. After 24 hr administration of BIC, BIC-NPs to SD rats at a dose of 5 mg/kg, respectively, the normal rats were used as the blank control group (blank). Data are expressed as mean ± SD (n = 5). Statistical analysis was performed by one-way factorial ANOVA, , vs. blank groups.
(a)
(b)
(c)
(d)